CXCL9 and cirrhosis of liver: Of note, Berres et al. [30] reported that patients with liver cirrhosis revealed increased CXCL9 concentrations; those with lower levels in portal and hepatic veins survive longer after transjugular intrahepatic portosystemic shunts (TIPS).